1. Adapting and Surviving: Intra and Extra-Cellular Remodeling in Drug-Resistant Gastric Cancer Cells
   Sabino Russi et al, 2019, International Journal of Molecular Sciences CrossRef
2. DKK1 Promotes Epithelial–Mesenchymal Transition and Cisplatin Resistance in Gastric Cancer via Activation of the PI3K/AKT Pathway
   Jian Li et al, 2023, Cancers CrossRef
3. MiR-874-3p represses the migration and invasion yet promotes the apoptosis and cisplatin sensitivity via being sponged by long intergenic non-coding RNA 00922 (LINC00922) and targeting Glycerophosphodiester Phosphodiesterase Domain Containing 5 (GDPD5) in gastric cancer cells
   Xiaoyu Zhang et al, 2022, Bioengineered CrossRef
4. Hippo Signaling Pathway and Cancer: Molecular Regulation and Therapeutic Targets
   Fariba Dehghanian et al, 2022, Precision Medicine and Clinical OMICS CrossRef
5. Overcoming therapeutic resistance to platinum-based drugs by targeting Epithelial–Mesenchymal transition
   Xirui Duan et al, 2022, Frontiers in Oncology CrossRef
6. Helicobacter pylori infection induces stem cell-like properties in Correa cascade of gastric cancer
   JunJian He et al, 2022, Cancer Letters CrossRef
7. Hippo in Gastric Cancer: From Signalling to Therapy
   Lornella Seeneevassen et al, 2022, Cancers CrossRef
8. Antitumor Effects of Paeoniflorin on Hippo Signaling Pathway in Gastric Cancer Cells
   Kai Niu et al, 2021, Journal of Oncology CrossRef
9. F-box protein 11 promotes the growth and metastasis of gastric cancer via PI3K/AKT pathway-mediated EMT
   Caixia Sun et al, 2018, Biomedicine & Pharmacotherapy CrossRef
10. Recent insight into the role and therapeutic potential of YAP/TAZ in gastrointestinal cancers
    Yifei Wang et al, 2022, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
11. A state-of-art of underlying molecular mechanisms and pharmacological interventions/nanotherapeutics for cisplatin resistance in gastric cancer
    Jitendra Gupta et al, 2023, Biomedicine & Pharmacotherapy CrossRef
12. The deadly cross-talk between Hippo pathway and epithelial–mesenchymal transition (EMT) in cancer
    Ioanna Akrida et al, 2022, Molecular Biology Reports CrossRef
13. Molecular Signaling Pathways Involved in Gastric Cancer Chemoresistance
    Henu Kumar Verma et al, 2020, Theranostics Approaches to Gastric and Colon Cancer CrossRef
14. Barth syndrome cardiomyopathy: targeting the mitochondria with elamipretide
    Hani N. Sabbah, 2021, Heart Failure Reviews CrossRef
15. TAZ Controls Helicobacter pylori-Induced Epithelial–Mesenchymal Transition and Cancer Stem Cell-Like Invasive and Tumorigenic Properties
    Camille Tiffon et al, 2020, Cells CrossRef
16. Association of the Epithelial–Mesenchymal Transition (EMT) with Cisplatin Resistance
    Milad Ashrafizadeh et al, 2020, International Journal of Molecular Sciences CrossRef
17. LncRNA MIR4435‐2HG functions as a ceRNA against miR‐125a‐5p and promotes neuroglioma development by upregulating TAZ
    Wangzhen Shen et al, 2021, Journal of Clinical Laboratory Analysis CrossRef